Outset Medical (OM) Gains from Investment Securities (2025)
Outset Medical (OM) posted quarterly Gains from Investment Securities of $4.4 million for Q1 2025.
Outset Medical (OM) Gains from Investment Securities (2025) Analysis & Trends
Outset Medical (OM) has reported Gains from Investment Securities for 1 consecutive years, with $4.4 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Gains from Investment Securities changed N/A year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (changed N/A YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
- Gains from Investment Securities held at $4.4 million in Q1 2025 per OM's latest filing.
- Across five years, Gains from Investment Securities topped out at $4.4 million in Q1 2025 and bottomed at $4.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.37 Mn |